Consistent with this hypothesis, Hasegawa et al. found increased CX3CR1 expression in inflammatory cells, colocalizing with CX3CL1 fractalkine-expressing endothelium in target organs such as lung and skin in SSc patients (17). Here, CX3CR1 is linked to systemic sclerosis.